Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

Republicans have long championed economic issues like lower taxes, free trade, and deregulation because it was the right ...

A small, early clinical trial led by the Icahn School of Medicine at Mount Sinai and collaborators has shown that directly ...

Enzalutamide plus leuprolide reduces the risk of death by more than 40% in biochemically recurrent prostate cancer compared to leuprolide alone.

Adding Pluvicto to standard therapy in metastatic patients led to a radiographic PFS benefit, but questions remain about ...

In a significant policy reversal, the National Institute for Health and Care Excellence (NICE) has recommended abiraterone ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

The latest update is out from Fusen Pharmaceutical Co., Ltd. ( ($HK:1652) ). Fusen Pharmaceutical Co., Ltd. announced the approval of its ...

Phase 3 ARENSENS clinical trial results were presented at JADPRO 2025, indicating darolutamide plus ADT improved rPFS in prostate cancer.

Androgen receptor pathway inhibitors (ARPIs) in combination with androgen deprivation therapy (ADT) represent the foundation ...

CLEARWATER, Fla. — Desnee Ebner-Rivers and the word, "cancer," do not get along. Not because she has cancer, but because of what it has taken from her. “I did. I lost all of them," said Ebner-Rivers.